Description
| Description | Reslizumab is humanized monoclonal antibodies that target interleukin-5 (IL-5) for the treatment of eosinophilic asthma. |
| Targets&IC50 | IL-5-dependent cell proliferation:91.1pM |
| Synonyms | Sch 55700 |
| Molecular Weight |
N/A |
| CAS No. | 241473-69-8 |
Storage
store at -20 ℃
Solubility Information
( < 1 mg/ml refers to the product slightly soluble or insoluble )
